Profile
Øystein Soug currently works at Oncoinvent ASA, as Chief Executive Officer from 2024 and Pharmasum Therapeutics AS, as Director.
Mr. Soug also formerly worked at Oncoinvent ASA (Old), as Chief Executive Officer, Arxx Therapeutics AS, as Chief Executive Officer from 2022 to 2023, Bionor Pharma ASA, as Director in 2013, Orkla ASA, as Chief Financial Officer-Russian Division, Algeta ASA, as CFO, Head-Finance, Administration & IR from 2012 to 2013, and Circio Holding ASA, as Chief Financial Officer from 2021 to 2022.
Mr. Soug received his graduate degree in 1997 from the University of St. Gallen.
Øystein Soug active positions
| Companies | Position | Start |
|---|---|---|
| ONCOINVENT ASA | Chief Executive Officer | 01/09/2024 |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Operates as a pharmaceutical company focusses on the discovery and development of novel human medicines for the treatment of brain diseases and neurological diseases | Director/Board Member | - |
Former positions of Øystein Soug
| Companies | Position | End |
|---|---|---|
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Chief Executive Officer | 01/12/2023 |
| CIRCIO HOLDING ASA | Chief Executive Officer | 20/10/2021 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Chief Executive Officer | - |
| ORKLA ASA | Director of Finance/CFO | - |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Director/Board Member | - |
Training of Øystein Soug
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Orkla ASA
Orkla ASA Food: Specialty/CandyConsumer Non-Durables Supplies branded consumer goods and concept solutions to the grocery and out-of-home sectors | Consumer Non-Durables |
University of St. Gallen
University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Operates as a pharmaceutical company focusses on the discovery and development of novel human medicines for the treatment of brain diseases and neurological diseases | Health Technology |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Health Technology |
- Stock Market
- Insiders
- Øystein Soug
















